AMOY DIAGNOSTICS

amoy-diagnostics-logo

Amoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx has a portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx's core product categories include single gene testing kits, multi-gene testing panels, NGS panels, and NGS analytical systems.

#SimilarOrganizations #People #Financial #Website #More

AMOY DIAGNOSTICS

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical Oncology Pharmaceutical Precision Medicine

Founded:
2008-01-01

Address:
Xiamen, Fujian, China

Country:
China

Website Url:
http://www.amoydx.com

Total Employee:
1001+

Status:
Active

Contact:
+86 592 680 6835

Email Addresses:
[email protected]

Total Funding:
164.24 M CNY

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Content Delivery Network Pound Sterling Japanese Yen China Ministry Of Public Security CNZZ


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

lucaspye-bio-logo

LucasPye BIO

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

not_available_image

MTAMTech Corp

Anti-cancer drug screening solution for application in personalized medicine and drug development

peroxitech-therapeutics-logo

Peroxitech Therapeutics

Peroxitech Therapeutics operates as a biopharmaceutical company.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.


Current Advisors List

william-hu_image

William Hu Board Of Directors @ Amoy Diagnostics
Board_member

Current Employees Featured

not_available_image

Zheng Limou
Zheng Limou Founder, President & CEO @ Amoy Diagnostics
Founder, President & CEO

anthony-marotta_image

Anthony Marotta
Anthony Marotta Medical Director & North America @ Amoy Diagnostics
Medical Director & North America
2020-01-01

Founder


not_available_image

Zheng Limou

Stock Details


Company's stock symbol is SZSE:300685

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - Amoy Diagnostics

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series A - Amoy Diagnostics

Official Site Inspections

http://www.amoydx.com Semrush global rank: 8.25 M Semrush visits lastest month: 595

  • Host name: 8.218.7.26
  • IP address: 8.218.7.26
  • Location: Singapore Singapore
  • Latitude: 1.2929
  • Longitude: 103.8547
  • Timezone: Asia/Singapore
  • Postal: 18

Loading ...

More informations about "Amoy Diagnostics"

AmoyDx

Organization: Telephone: Country: ... AmoyDx is excited to be part of this incredible gathering for oncology community. Our team has been all geared up to engage with you at booth #520, hall …See details»

Our Company - [AmoyDx] - Amoy Diagnostics

Welcome to AmoyDx. A visionary diagnostic company dedicated to transforming the landscape of cancer care. 'Breaking Barriers to Precision Oncology' reflects our commitment to …See details»

Amoy Diagnostics - Crunchbase Company Profile

Amoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx …See details»

Amoy Diagnostics Co Ltd - Company Profile - GlobalData

Amoy Diagnostics Co Ltd (AmoyDx) is a developer of molecular diagnostics for oncology precision medicine. The company's product portfolio comprises single-gene testing kits, multi …See details»

Amoy Diagnostics - LinkedIn

Amoy Diagnostics (AmoyDx) is a visionary diagnostic company dedicated to transforming the landscape of cancer care. 'Breaking Barriers to Precision Oncology' reflects our commitment to ...See details»

Global Presence - [AmoyDx] - Amoy Diagnostics

Organization: Telephone: Country: ... Login. Global Distributor Network. AmoyDx has been focusing on companion diagnostics for nearly 20 years. A worldwide network has been soundly established to deliver our commitment to …See details»

AmoyDx - Products, Competitors, Financials, Employees, …

AmoyDx specializes in molecular diagnostics within the precision oncology field, focusing on the development and provision of diagnostic products and services that benefit patients through …See details»

Amoy Diagnostics - Craft

Oct 9, 2024 Amoy Diagnostics has 5 employees at their 1 location and ¥1.03 b in annual revenue in FY 2023. See insights on Amoy Diagnostics including office locations, competitors, …See details»

AmoyDx - Overview, News & Similar companies | ZoomInfo.com

Apr 18, 2022 AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO® (tepotinib) TOKYO and XIAMEN, China, Aug. 17, 2021 (GLOBE …See details»

Abstract of 2018 Annual Report of Amoy Diagnostics Co., Ltd.

Security Code: 300685 Stock Abbreviation: AmoyDx Announcement No: 2019-026 Abstract of 2018 Annual Report of Amoy Diagnostics Co., Ltd. Notes:In the event of discrepancy between …See details»

AmoyDx Company Profile 2025: Stock Performance

AmoyDx has 1,119 total employees. What industry is AmoyDx in? AmoyDx’s primary industry is Biotechnology. Is AmoyDx a private or public company? AmoyDx is a Public company. What is AmoyDx’s stock symbol? The ticker …See details»

Amoy Diagnostics onboarding international talent with G-P

The organization has ventured into new markets and expanded the talent pool from which it can hire. Providing new team members with the best experience is critical to AmoyDx. G-P’s …See details»

AmoyDx Enters into Master Collaboration Agreement with …

Apr 18, 2022 The AmoyDx decentralized CDx are based on the HANDLE ® system, a proprietary NGS library construction technology developed by AmoyDx, that can enable the …See details»

AmoyDx® Master Panel - [AmoyDx] - Amoy Diagnostics

Organization: Telephone: Country: ... The AmoyDx® Master Panel targets over 40 solid tumor types, enabling the effective and reliable assessment of both actionable and emerging …See details»

AmoyDx - Stratech

AmoyDx® PIK3CA Mutation Detection Kit is a real-time PCR assay for in vitro diagnostics (IVD). The kit allows for the qualitative detection of up to 11 somatic mutations in the PIK3CA gene, …See details»

艾德生物 - 官网 - amoydx.com

艾德生物“AmoyDx Pan lung cancer PCR panel”(即艾惠健®升级版,已在日本获得注册受理)将作为伴随诊断配合海和生物在研MET抑制剂谷美替尼(glumetinib,SCC244)在日本进行药 …See details»

Sensitive Detection of KRAS Mutations by Clustered Regularly

Health Organization classification. DNA extraction. We extracted DNA using the DNeasy kit (Qiagen, Valencia, CA, USA) as described in our previous publications [9–14]. We eluted DNA …See details»

NGS Technology Technology - [AmoyDx]

Organization: Telephone: Country: ... AmoyDx dual-directional capture (ddCapture) technology is a proprietary capture-based approach that utilizes biotinylated oligonucleotide baits (probes) to …See details»

Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …

20 hours ago CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan …See details»

Technology - [AmoyDx] - Amoy Diagnostics

A visionary diagnostic company dedicated to transforming the landscape of cancer care. 'Breaking Barriers to Precision Oncology' reflects our commitment to revolutionizing cancer diagnosis …See details»

linkstock.net © 2022. All rights reserved